We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALVAL market cap is 61.99M. The company's latest EPS is EUR -0.7795 and P/E is -5.03.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 1.52M | 1.91M | 5.1M | 2.71M | 2.83M |
Operating Income | -4.79M | -5.13M | -3.37M | -8.48M | -12.03M |
Net Income | -4.97M | -5.5M | -3.83M | -8.68M | -12.31M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 11.91M | 15.06M | 21.08M | 28.54M | 27.22M |
Total Liabilities | 4.5M | 6.81M | 13.93M | 14.25M | 13.86M |
Total Equity | 7.41M | 8.25M | 7.15M | 14.3M | 13.36M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -4.55M | -4.95M | 2.69M | -7.16M | -9.19M |
Investing | -723k | -290k | -332k | -7k | -197k |
Financing | 2.09M | 5.85M | 4.19M | 14.4M | 8.4M |
Market Cap | 61.99M |
Price to Earnings Ratio | -5.03 |
Price to Sales Ratio | 21.9 |
Price to Cash Ratio | 2.97 |
Price to Book Ratio | 4.64 |
Dividend Yield | - |
Shares Outstanding | 15.79M |
Average Volume (1 week) | 13.1k |
Average Volume (1 Month) | 31.78k |
52 Week Change | 15.10% |
52 Week High | 7.50 |
52 Week Low | 2.82 |
Spread (Intraday) | 0.09 (2.27%) |
Company Name | Valbiotis SA |
Address |
zi des quatre chevaliers 12f rue paul vatine paris, paris 17180 |
Website | https://www.valbiotis.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions